Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq’s Minimum Bid Price Requirement and Completes Debt Settlements
TORONTO, ON / ACCESSWIRE / September 6, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or...